Range
4.13 - 4.5
Vol / Avg.
1M/-
Div / Yield
-
52 Wk
- - -
Mkt Cap
188.1M
Payout Ratio
-
Open
4.5
P/E
-
EPS
-0.16
Shares
42.9M
Outstanding
42.9M
Total Float
-
Cardiol Therapeutics Inc is a biotech company focused on developing therapies for cardiovascular disease. Their lead product, CardiolRx, is a pharmaceutical cannabidiol formulation being investigated in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for cardiovascular disease. The company is also being investigated in patients with acute myocarditis, a leading cause of cardiac death in people less than 35 years old.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Cardiol Therapeutics Questions & Anwsers

Q

How do I buy Cardiol Therapeutics (CRDL) stock?

A

You can purchase shares of Cardiol Therapeutics (NASDAQ: CRDL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cardiol Therapeutics's (CRDL) competitors?

A

There are no as such competitors for Cardiol Therapeutics.

Q

What is the target price for Cardiol Therapeutics (CRDL) stock?

A

There is no analysis for Cardiol Therapeutics

Q

Current Stock Price for Cardiol Therapeutics (CRDL)?

A

The stock price for Cardiol Therapeutics (NASDAQ: CRDL) is $4.38 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Cardiol Therapeutics (CRDL) pay a dividend?

A

There are no upcoming dividends for Cardiol Therapeutics.

Q

When is Cardiol Therapeutics (NASDAQ:CRDL) reporting earnings?

A

Cardiol Therapeutics does not have any upcoming earnings scheduled.

Q

Is Cardiol Therapeutics (CRDL) going to split?

A

There is no upcoming split for Cardiol Therapeutics.

Q

What sector and industry does Cardiol Therapeutics (CRDL) operate in?

A

Cardiol Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.